Kriti Mehra
Hematology & Oncology · Springfield, MANPI 1487264933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,148 and has fallen 51.0% since, to $563 in 2024.
Across 147 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$728
- AbbVie$485
- E.r. Squibb & Sons, L.L.C.$374
- Johnson & Johnson$305
- Gilead$295
- Bayer$276
- plus $854 from 15 others
What the payments were for
- Food & beverage$3,318100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 28 | $728 |
| AbbVie | 18 | $485 |
| E.r. Squibb & Sons, L.L.C. | 19 | $374 |
| Johnson & Johnson | 12 | $305 |
| Gilead | 12 | $295 |
| Bayer | 14 | $276 |
| Pfizer | 11 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $128 |
| Boehringer Ingelheim | 7 | $111 |
| Fresenius Kabi USA, LLC | 3 | $67 |
| Novo Nordisk | 3 | $64 |
| Grifols USA, LLC | 2 | $55 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Incyte Corporation | 2 | $37 |
| Karyopharm Therapeutics Inc. | 2 | $32 |
| Argenx US, Inc. | 1 | $31 |
| GSK | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Alcresta Therapeutics, Inc. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
How this compares
$3,318 in reported general payments places this provider in the 60th percentile of 374 hematology & oncology providers in Massachusetts.
Other hematology & oncology in Springfield
- David ScaddenBoston$2.6M
- Sara TolaneyBoston$799K
- Matthew DavidsBoston$693K
- Stephanie BernsteinWinchester$622K
- Julio HajdenbergBoston$583K
- Paul RichardsonBoston$523K
- Seth WanderBoston$464K
- Corey CutlerBoston$454K
- Hanny Al-SamkariBoston$412K
- Karl DsilvaPeabody$383K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.